REV-MED Unveils New Products, Including NovaStem, at Korea Derma 2023
REV-MED has launched the NovaStem kit and Brifill hyaluronic acid filler, designed to support anti-aging treatments, at its booth during Korea Derma 2023. These innovations highlight REV-MED’s expertise in stem cell research and cutting-edge technology.
REV-MED's Innovations in Anti-Aging
Korea Derma 2023, organized by the Korean Dermatological Association, is a global gathering of dermatology specialists showcasing the latest advancements in skincare and anti-aging. REV-MED, founded in 2009, leveraged this platform to expand its business into the rapidly growing anti-aging sector.
The newly launched Brifill—a combination of “Bright” and “Filler”—is a long-lasting and safe hyaluronic acid filler. Alongside this, REV-MED introduced the TriCell PRP Kit, a bio-kit designed to extract growth and regenerative factors from blood, bone marrow, and adipose tissue. These products have already demonstrated success in vascular and orthopedic treatments and are now extended to anti-aging with the launch of NovaStem.
About NovaStem: Revolutionizing Stem Cell Anti-Aging Treatments
NovaStem is a stem cell-based anti-aging treatment platform designed to enhance immunity, improve hair loss, and boost skin elasticity. Unlike the TriCell Kit, NovaStem is specifically engineered for intravenous use, delivering regenerative factors extracted from stem cells directly into the bloodstream via an infusion bag.
Key innovations in NovaStem include:
- A dual-layer system to minimize contamination risk.
- Special processing to prevent adhesion between stem cells and growth factors, ensuring efficient extraction.
- Use of non-toxic, heat-resistant materials during centrifugation for safe and effective cell processing.
- Minimal needle usage to reduce cellular stress and damage.
Clinical Insights and Future Plans
Dr. Dae-Kwan Kim, Senior Researcher at REV-MED’s Stem Cell Research Center, noted, “NovaStem contains hematopoietic stem cells, enhancing the activity and proliferation of immune cells like NK cells, thereby improving immunity. Additionally, it promotes hair growth, with supporting research published in 2020.”
Soo Jae-Hong, Director of Global Business Development, added, “We are preparing regulatory approvals from the Ministry of Food and Drug Safety (MFDS) in Korea, Europe, and Japan’s Ministry of Health. The NovaStem anti-aging program will be supported with structured training to ensure safe and effective treatments at medical institutions.”
A Strategic Leap into Anti-Aging
CEO Edward BG Shin expressed his enthusiasm, stating, “Korea Derma 2023 marks a meaningful milestone for REV-MED as we showcase our new ventures in the anti-aging market. We hope our stem cell technologies will make a significant impact on clinical practices and contribute to public health improvement.”
With its innovative products and dedication to expanding the possibilities of stem cell therapy, REV-MED is well-positioned to lead advancements in the global anti-aging market.
Source : HealthTrends (http://www.k-health.com)
REV-MED Unveils New Products, Including NovaStem, at Korea Derma 2023
REV-MED has launched the NovaStem kit and Brifill hyaluronic acid filler, designed to support anti-aging treatments, at its booth during Korea Derma 2023. These innovations highlight REV-MED’s expertise in stem cell research and cutting-edge technology.
REV-MED's Innovations in Anti-Aging
Korea Derma 2023, organized by the Korean Dermatological Association, is a global gathering of dermatology specialists showcasing the latest advancements in skincare and anti-aging. REV-MED, founded in 2009, leveraged this platform to expand its business into the rapidly growing anti-aging sector.
The newly launched Brifill—a combination of “Bright” and “Filler”—is a long-lasting and safe hyaluronic acid filler. Alongside this, REV-MED introduced the TriCell PRP Kit, a bio-kit designed to extract growth and regenerative factors from blood, bone marrow, and adipose tissue. These products have already demonstrated success in vascular and orthopedic treatments and are now extended to anti-aging with the launch of NovaStem.
About NovaStem: Revolutionizing Stem Cell Anti-Aging Treatments
NovaStem is a stem cell-based anti-aging treatment platform designed to enhance immunity, improve hair loss, and boost skin elasticity. Unlike the TriCell Kit, NovaStem is specifically engineered for intravenous use, delivering regenerative factors extracted from stem cells directly into the bloodstream via an infusion bag.
Key innovations in NovaStem include:
Clinical Insights and Future Plans
Dr. Dae-Kwan Kim, Senior Researcher at REV-MED’s Stem Cell Research Center, noted, “NovaStem contains hematopoietic stem cells, enhancing the activity and proliferation of immune cells like NK cells, thereby improving immunity. Additionally, it promotes hair growth, with supporting research published in 2020.”
Soo Jae-Hong, Director of Global Business Development, added, “We are preparing regulatory approvals from the Ministry of Food and Drug Safety (MFDS) in Korea, Europe, and Japan’s Ministry of Health. The NovaStem anti-aging program will be supported with structured training to ensure safe and effective treatments at medical institutions.”
A Strategic Leap into Anti-Aging
CEO Edward BG Shin expressed his enthusiasm, stating, “Korea Derma 2023 marks a meaningful milestone for REV-MED as we showcase our new ventures in the anti-aging market. We hope our stem cell technologies will make a significant impact on clinical practices and contribute to public health improvement.”
With its innovative products and dedication to expanding the possibilities of stem cell therapy, REV-MED is well-positioned to lead advancements in the global anti-aging market.
Source : HealthTrends (http://www.k-health.com)